Vivozon Pharmaceutical Co., Ltd. (KOSDAQ:082800)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,165.00
-95.00 (-2.91%)
At close: Apr 28, 2026
-53.52%
Market Cap 190.42B
Revenue (ttm) 59.34B
Net Income (ttm) -32.42B
Shares Out 60.16M
EPS (ttm) -655.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 250,554
Average Volume 286,540
Open 3,260.00
Previous Close 3,260.00
Day's Range 3,140.00 - 3,295.00
52-Week Range 2,970.00 - 8,800.00
Beta -0.41
RSI 44.10
Earnings Date Apr 3, 2026

About Vivozon Pharmaceutical

Vivozon Pharmaceutical Co., Ltd. researches, develops, produces, and sells LED products primarily in South Korea. The company offers LED packages for interior, general, indoor, decorative, and automotive lighting, as well as display applications. It also provides LED set linear lamps for offices, houses, apartments, buildings, factories, and parking lots. In addition, the company operates Echo House, a lighting show room that sells LED florescent lamps. The company was formerly known as Vivozon Healthcare, Inc. and changed its name to Vivozon P... [Read more]

Industry Pharmaceutical Preparations
Founded 2002
Employees 307
Stock Exchange KOSDAQ
Ticker Symbol 082800
Full Company Profile

Financial Performance

In 2025, Vivozon Pharmaceutical's revenue was 59.34 billion, a decrease of -32.26% compared to the previous year's 87.60 billion. Losses were -32.42 billion, 224.8% more than in 2024.

Financial Statements

News

There is no news available yet.